Skip to main content
main-content

01.08.2011 | Research | Ausgabe 4/2011 Open Access

Critical Care 4/2011

The clinical and functional relevance of microparticles induced by activated protein C treatment in sepsis

Zeitschrift:
Critical Care > Ausgabe 4/2011
Autoren:
Margarita Pérez-Casal, Victoria Thompson, Colin Downey, Ingeborg Welters, Duncan Wyncoll, Jecko Thachil, Cheng Hock Toh
Wichtige Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​cc10356) contains supplementary material, which is available to authorized users.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

MPC participated in the study design and coordination, carried out the molecular genetic studies and functional assays, and helped to draft the manuscript. VT carried out the MP number experiments and functional assays and helped to draft the manuscript. CD carried out the MP number experiments. IW and DW contributed patient samples. JT helped to draft the manuscript. CHT conceived of the study and participated in its design and coordination and helped to draft the manuscript. All authors read and approved the final manuscript.

Abstract

Introduction

Activated protein C (APC) induces release of microparticles (MP) from primary physiological cells, which are found in patients undergoing treatment with recombinant human APC (rhAPC) for severe sepsis. We hypothesised that APC on these circulating MPs activate endothelial protease-activated receptor 1 (PAR1) to induce anti-apoptotic and anti-inflammatory properties that can improve patient outcome.

Methods

This was an experimental study on clinical samples in an intensive care setting, and included patients with severe sepsis who fulfilled criteria for treatment with rhAPC. The number of CD13+ MPs from the patients were analysed to determine their origin. They were also quantified for endothelial protein C receptor (EPCR) and APC expression. Clinical relevance of these MPs were ascertained by comparing survival between the group receiving rhAPC (n = 25) and a control group of untreated patients (n = 25). MPs were also incubated with endothelial cells to analyse apoptotic gene expression, cytoprotection and anti-inflammatory effects.

Results

rhAPC treatment induced a significant increase in circulating MP-associated EPCR by flow cytometry (P < 0.05) and by quantitative ELISA (P < 0.005). APC expression also showed significant increases (P < 0.05). Numerically, CD13+ MPs were higher in rhAPC-treated survivors versus non-survivors. However, the number of non-survivors was low and this was not significantly different. APC on MPs was demonstrated to induce anti-apoptotic and endothelial barrier effects through the activation of endothelial PAR1.

Conclusions

rhAPC treatment in patients with sepsis significantly increases circulating EPCR + MPs. These MPs were noted to express APC, which has specific anti-apoptotic and anti-inflammatory effects, with a non-significant correlative trend towards survival. This suggests that MPs could disseminate APC function and activate endothelial PAR1 at distal vascular sites.
Zusatzmaterial
Additional file 2:Supplementary Figure S1. The proportion of free versus bound rhAPC on microparticles. Comparison of results obtained from patient samples to in vitro derived MPs. (TIFF 31 KB)
13054_2011_9615_MOESM2_ESM.TIFF
Additional file 3:Supplementary table S1. Genes modulated by APC (free or microparticle [MP]-bound from patients). Microarray results. (DOCX 17 KB)
13054_2011_9615_MOESM3_ESM.DOCX
Authors’ original file for figure 1
13054_2011_9615_MOESM4_ESM.tiff
Authors’ original file for figure 2
13054_2011_9615_MOESM5_ESM.tiff
Authors’ original file for figure 3
13054_2011_9615_MOESM6_ESM.tiff
Authors’ original file for figure 4
13054_2011_9615_MOESM7_ESM.tiff
Authors’ original file for figure 5
13054_2011_9615_MOESM8_ESM.tiff
Authors’ original file for figure 7
13054_2011_9615_MOESM9_ESM.tiff
Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 4/2011

Critical Care 4/2011 Zur Ausgabe

Neu im Fachgebiet AINS

Meistgelesene Bücher aus dem Fachgebiet AINS

  • 2014 | Buch

    Komplikationen in der Anästhesie

    Fallbeispiele Analyse Prävention

    Aus Fehlern lernen und dadurch Zwischenfälle vermeiden! Komplikationen oder Zwischenfälle in der Anästhesie können für Patienten schwerwiegende Folgen haben. Häufig sind sie eine Kombination menschlicher, organisatorischer und technischer Fehler.

    Herausgeber:
    Matthias Hübler, Thea Koch
  • 2013 | Buch

    Anästhesie Fragen und Antworten

    1655 Fakten für die Facharztprüfung und das Europäische Diplom für Anästhesiologie und Intensivmedizin (DESA)

    Mit Sicherheit erfolgreich in Prüfung und Praxis! Effektiv wiederholen und im entscheidenden Moment die richtigen Antworten parat haben - dafür ist dieses beliebte Prüfungsbuch garantiert hilfreich. Anhand der Multiple-Choice-Fragen ist die optimale Vorbereitung auf das Prüfungsprinzip der D.E.A.A. gewährleistet.

    Autoren:
    Prof. Dr. Franz Kehl, Dr. Hans-Joachim Wilke
  • 2011 | Buch

    Pharmakotherapie in der Anästhesie und Intensivmedizin

    Wie und wieso wirken vasoaktive Substanzen und wie werden sie wirksam eingesetzt Welche Substanzen eignen sich zur perioperativen Myokardprojektion? 
    Kenntnisse zur Pharmakologie und deren Anwendung sind das notwendige Rüstzeug für den Anästhesisten und Intensivmediziner. Lernen Sie von erfahrenen Anästhesisten und Pharmakologen.

    Herausgeber:
    Prof. Dr. Peter H. Tonner, Prof. Dr. Lutz Hein
  • 2013 | Buch

    Anästhesie und Intensivmedizin – Prüfungswissen

    für die Fachpflege

    Fit in Theorie, Praxis und Prüfung! In diesem Arbeitsbuch werden alle Fakten der Fachweiterbildung abgebildet. So können Fachweiterbildungsteilnehmer wie auch langjährige Mitarbeiter in der Anästhesie und Intensivmedizin ihr Wissen gezielt überprüfen, vertiefen und festigen.

    Autor:
    Prof. Dr. Reinhard Larsen

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update AINS und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise